FDA issued a Warning Letter to Bristol Myers Squibb Holdings Pharma., Ltd. on 8/30/2010 for a previous inspection.
483 Bristol-Myers Squibb Holdings Pharma Liability Company Feb 2019

483 Bristol-Myers Squibb Holdings Pharma Liability Company Feb 2019

Libia Lugo FDA$119.00 - Available Now

FDA investigators audited the Bristol-Myers Squibb Holdings Pharma Liability Company - Manati, PR, United States facility and issued inspectional observations (via FDA 483) on 06 Feb 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 06 Feb 2019
  • Location: Manati, United States
  • FEI: 2650089
Add To Cart